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In Brief
Boulenouar et al. define different subsets
of type 1 innate lymphoid cells (AT1-ILCs)
in human and murine adipose tissues and
show that at steady state, AT1-ILCs kill
adipose tissue macrophages (ATMs). In
obesity, cytotoxicity is impaired.
Interference with AT1-ILC cytotoxicity
impacted ATM homeostasis and
systemic metabolism, pointing to its
importance in homeostasis and disease.
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Adipose tissue has a dynamic immune system that
adapts to changes in diet andmaintains homeostatic
tissue remodeling. Adipose type 1 innate lymphoid
cells (AT1-ILCs) promote pro-inflammatory macro-
phages in obesity, but little is known about their func-
tions at steady state. Here we found that human and
murine adipose tissue harbor heterogeneous popu-
lations of AT1-ILCs. Experiments using parabiotic
mice fed a high-fat diet (HFD) showed differential
trafficking of AT1-ILCs, particularly in response to
short- and long-term HFD and diet restriction. At
steady state, AT1-ILCs displayed cytotoxic activity
toward adipose tissue macrophages (ATMs). Deple-
tion of AT1-ILCs and perforin deficiency resulted
in alterations in the ratio of inflammatory to anti-in-
flammatory ATMs, and adoptive transfer of AT1-
ILCs exacerbated metabolic disorder. Diet-induced
obesity impaired AT1-ILC killing ability. Our findings
reveal a role for AT1-ILCs in regulating ATM homeo-
stasis through cytotoxicity and suggest that this
function is relevant in both homeostasis and meta-
bolic disease.
INTRODUCTION
The last decade has revealed that adipose tissue (AT) is not just
an inert energy storage tissue but is essential for metabolic
health through the production of a diverse array of adipokines
and due to the unique adipose-resident immune system (Exley
et al., 2014; Kanneganti and Dixit, 2012). A key feature of AT is
its ability to respond to changes in nutrient fluctuations, expand-
ing and contracting to deal with changes in energy intake (Rosen
and Spiegelman, 2014). It is now clear that the adipose
immune system plays an important role in adipose homeostasis.
In the lean state, adipose tissue is enriched with regulatory cellsincluding Treg cells, regulatory iNKT cells, eosinophils, type 2
innate lymphoid cells (ILC2s), and alternatively activated ‘‘M2’’
macrophages (Brestoff et al., 2015; Feuerer et al., 2009; Lynch
et al., 2009a, 2012; Wu et al., 2011). This regulatory immune sys-
tem is critical formaintaining ametabolically healthy state and for
keeping inflammation at bay during tissue fluctuations (Exley
et al., 2014). The adipose response to excess energy or fasting
can trigger a local immune response, and this needs to be kept
in check to prevent aberrant responses and damage. In obesity,
there is an immune response to excess energy, which subse-
quently contributes to metabolic disorder. Adipocyte hypertro-
phy in obesity leads to lipid release, stress signals, and chemo-
kines that attract and activate ‘‘M1’’ macrophages and other
pro-inflammatory immune cells (Lumeng et al., 2007). At the
same time, the adipose-resident regulatory immune cells are
lost, leading to uncontrolled chronic inflammation (Feuerer
et al., 2009; Ji et al., 2012; Lynch et al., 2009a, 2012; Schipper
et al., 2012). This response contributes to local and systemic in-
creases in pro-inflammatory cytokines like TNF-a, which inter-
fere with insulin signaling leading to insulin resistance (Hotamisli-
gil et al., 1993; Kahn and Flier, 2000).Much research has focused
on this harmful inflammatory response, but less is known about
the resident immune system in steady state that likely plays crit-
ical functions in normal adipose homeostasis. Furthermore, it is
often forgotten that the physiological response of adipose tissue
macrophages (ATMs) and other immune cells is likely beneficial
in the early stage of obesity. For example, ATMs provide a buff-
ering protection against lipotoxicity through uptake of free lipids
that would be toxic locally and systemically (Fischer-Posovszky
et al., 2011; Xu et al., 2013). Lipid-filled ATMs also accumulate
during fasting, caloric restriction, and pharmacologically
induced lipolysis, suggesting that ATMs are an important physi-
ological response to perturbations in adipose tissue (Kosteli
et al., 2010; Sun et al., 2011). Understanding the adipose-resi-
dent immune system at steady state is important for our appre-
ciation of adipose immunity and for preventing inflammation-
induced metabolic disorder.
Recently, type 1 innate lymphoid cells (T1-ILCs), including
their founding member, natural killer (NK) cells, joined the dy-
namic immune response that occurs in AT in response to obesityImmunity 46, 273–286, February 21, 2017 ª 2017 Elsevier Inc. 273
(Lee et al., 2016; O’Sullivan et al., 2016; Wensveen et al.,
2015). Adipose T1-ILCs (AT1-ILCs) played a pathogenic role
by promoting pro-inflammatory M1 macrophages that underlie
obesity-associated insulin resistance. However, T1-ILCs repre-
sent a major component of the adipose lymphoid compartment
at steady state, and their role in lean AT has not been studied.
In addition, it is unknown whether T1-ILCs interact with macro-
phages at steady state in lean mice, when the majority of
ATMs are anti-inflammatory tissue repair-associated M2 pheno-
type. Indeed, NK cells and macrophages can cooperate to clear
infections in many tissues. Macrophages and monocytes can
activate NK cells through soluble factors (i.e., IL-12 and IL-18)
and NK cells secrete IFN-g which potentiates macrophage/
monocytes activation (Michel et al., 2013). NK cells can kill
endogenous infected or LPS-activated macrophages, likely
preventing further damage to the host (Lapaque et al., 2009;
Nedvetzki et al., 2007). However, it is now appreciated that
T1-ILCs are expanding and NK cells are no longer the sole
component of this group. Diverse ILC1s are frequently identified
in different tissues and can be also classified as T1-ILCs (Cortez
and Colonna, 2016; Seillet and Belz, 2016; Spits et al., 2016).
In murine adipose tissue, using GFP-reporter mice, three major
AT1-ILC populations were recently identified: (1) mature NK
(mNK) cells, (2) immature NK (iNK) cells, and (3) ILC1s. ILC1s
were reported to be the major contributors for IFN-g upregula-
tion during diet-induced obesity resulting in the expansion of
pro-inflammatory M1 macrophages (O’Sullivan et al., 2016),
similar to the previous report on the role of adipose NK cells in
obesity (Wensveen et al., 2015). However, the precise interaction
between each AT1-ILC subsets with macrophages at steady
state and during obesity remains unclear.
Here, we examined human and murine adipose tissue and
found heterogeneous populations of AT1-ILCs. Based on the
expression of surface cell markers, transcription factors, cyto-
kines, and cytotoxicity signatures that define type 1 ILCs, we
identified three major subsets in mouse and two subsets in hu-
man adipose tissue. These subsets displayed distinct trafficking
characteristics and differential plasticity in lean and obese states
and after weight loss. We examined each AT1-ILC subset at
steady state and found that all subsets displayed cytotoxic activ-
ity toward ATM. This killing ability was impaired during obesity
and could contribute to the skewing toward a pathogenic accu-
mulation of pro-inflammatory macrophages.
RESULTS
Type 1 ILCs Are Enriched in Human and Mouse Adipose
Tissues and Are Predominantly Tissue Resident
Recent reports have shown that AT has a substantial immune
system with an enrichment of innate immune cells (Brestoff
and Artis, 2015; Exley et al., 2014). Most recently, NK cells and
other T1-ILC subsets have been described inmurine adipose tis-
sue in obesity (Lee et al., 2016; O’Sullivan et al., 2016; Wensveen
et al., 2015). Little is known about T1-ILCs in adipose tissue at
steady state in mice and humans. In humans, different T1-ILCs
were identified in lymphoid and non-lymphoid peripheral tissues
based on the lack of c-Kit and ROR-gt (Bjo¨rkstro¨m et al., 2016;
Spits et al., 2016). We found that CD56+CD3 cells in human ad-
ipose tissue do not express c-Kit and ROR-gt (Figure S1A) and274 Immunity 46, 273–286, February 21, 2017we identified them as T1-ILCs. In visceral omental fat, T1-ILCs
were enriched (7%–20% of omental lymphocytes) compared
to matched blood (5%–12% of peripheral lymphocytes; Fig-
ure 1A). To investigate whether T1-ILC enrichment was specific
to omentum, we collected samples from four distinct adipose
compartments from seven non-obese individuals undergoing
abdominal surgery. All human adipose depots examined con-
tained substantial levels of T1-ILCs (5%–10% of resident lym-
phocytes; Figure 1B), although omentum has the highest fre-
quency and number (Figures 1B and 1C).
In mice, epididymal white adipose tissue (WAT) was highly
enriched with NK1.1+CD3 cells at steady state, showing the
highest frequency among all organs tested (Figures 1D and
S1B). Recently, adipose NK1.1+Lin cells were identified as T1-
ILCs that expressed T-bet and showed no history of ROR-gt
expression (O’Sullivan et al., 2016). It was also shown earlier
that in obesity, adipose NK1.1+CD3 cells did not express other
ILCs receptor/markers such as IL-7R-a and c-Kit (Wensveen
et al., 2015). Here, we report that at steady state, murine T1-
ILCs constituted 22%–30% of adipose lymphocytes, compared
to 7% in blood, 3% in spleen and peritoneal fluid, 12% in
liver, <1% in the lymph node and thymus, and 5% in bone
marrow (Figures 1D and S1B). We also found significant propor-
tions of T1-ILCs in all other adipose depots examined, including
brownadipose tissue (BAT),peri-renal,mesenteric, andsub-cuta-
neous adipose tissue, although the highest levels were seen in
epididymal and female parametrial depots (Figure S1C). T1-ILCs
were not only enriched in adipose tissue compared to other sites,
but also were the most abundant lymphocyte population in adi-
pose tissue (Figure 1E). Similar findings were seen in BALB/c
mice (data not shown), suggesting their enrichment is not refined
to onemouse strain. T1-ILCs levels fluctuatedwith age, with peak
levels between8 and30weeks old,whichdeclined to significantly
lower levels in 1-year-old animals (Figure 1F).
We then asked whether adipose T1-ILCs were resident or
constantly recirculating through adipose from the periphery.
We generated parabiotic mice with congenic CD45.1 and
CD45.2 mice. During the healing process after surgery, capillary
anastomoses form between the two vascular systems, allowing
for exchange of circulating peripheral blood cells. After 2 weeks
of parabiosis, T1-ILCs recirculated completely in the blood
and spleen between the two parabiotic partners (Figure 1G).
T1-ILCs in liver circulated less, reaching 30% chimerism, con-
firming previous findings (Sojka et al., 2014). However, only about
one-fifth of adipose T1-ILCs were partner derived (Figure 1G). To
confirm that low chimerism of T1-ILCs in adipose tissue was not
due to low circulation dynamics of all adipose lymphocytes, we
compared T1-ILC recirculation to other lymphocyte populations
in adipose tissue. B cells andCD8 T cells completely recirculated
through adipose tissue, reaching levels that approach 50%
chimerism, indicating almost full exchange (Figure 1H). Our
findings suggest that T1-ILCs are enriched in adipose tissue
where they are largely resident and rely less on infiltration from
the periphery, unlike spleen where they constantly recirculate.
Unique T1-ILC Subsets Populate Mouse Adipose Tissue
at Steady-State
Given that T1-ILCs display a more resident phenotype than else-
where, we hypothesized that they might have a distinct adipose
Figure 1. Adipose AT1-ILCs Are Enriched in Human and Mouse Adipose Tissues
(A) Representative flow cytometry plots of human AT1-ILC CD56+CD3 cells in matched blood and omental adipose tissue.
(B and C) T1-ILCs levels (B) and recovered numbers (C) in human matched adipose tissue depots (n = 5–8 per sample).
(D) Representative contour plots of mouse T1-ILCs (NK1.1+CD3) in matched blood, liver, spleen, peritoneal fluid, bone marrow (BM), thymus, peripheral lymph
node, brown adipose tissue (BAT), and white epididymal adipose tissue (WAT) in WT C57BL/6 mice.
(E) Pie chart indicates the proportions of all lymphocyte populations in murine epididymal tissue in 6- to 8-week-old C57BL/6 mice.
(F) Graphs of mouse T1-ILCs (NK1.1+CD3) in adipose tissue in young and aged C57BL/6 mice (4–60 weeks).
(G) CD45.1 and CD45.2 congenic mice were joined in parabiotic pairs (5 pairs) at 6 weeks of age for 3 weeks. Representative FACS dot plots gated on T1-ILCs
from blood, spleen, liver, and fat of the CD45.1 member of a parabiotic pair after 15 days of parabiosis show the relative frequencies of CD45.1 (host) and CD45.2
(parabiotic partner) T1-ILCs in each organ.
(H) Pie charts indicate the average of the relative frequencies of CD45.1 (gray) and CD45.2 (black) cells from 5 parabiotic pairs after 15 days in CD45.1 partner of
each pair.
Error bars represent SEM. Statistical comparisons using unpaired two-tailed Student’s t test. *p < 0.05, **p% 0.01, ***p < 0.001. See also Figure S1.phenotype. Unusually, the majority of AT1-ILCs expressed
low or no Ly49 markers, suggesting that they are uneducated
(Figure S2A). However, the bimodal expression profile of Thy1
and NKG2A (Figure S2A) prompted us to question whether
AT1-ILCs comprised heterogeneous subsets. Hence, we per-
formed an in-depth phenotypic analysis. Tissue-resident ILC1s
are distinguished from circulating cNK cells in several tissues
including liver, skin, salivary glands (Cortez et al., 2014), and
uterus by the expression of CD49a and DX5 markers (Boule-nouar et al., 2016; Peng et al., 2013; Sojka et al., 2014). First,
based on CD49a and DX5 surface expression, we identified
that AT1-ILCs (NK1.1+NKp46+CD3) are made up of four
subsets which we have annotated as double negative (DN,
DX5CD49a), ILC1-like (DX5CD49a+), double positive (DP,
DX5+CD49a+), and conventional (cNK, DX5+CD49a) NK cells
(Figure 2A). The composition of T1-ILC subsets was unique in
adipose tissue. cNK cells were much fewer (30%), while DN
and ILC1-like subsets were enriched, and a DP populationImmunity 46, 273–286, February 21, 2017 275
Figure 2. Unique T1-ILC Subsets Populate Mouse Adipose Tissue at Steady State and Are Distinct from Spleen and Liver ILC1s
(A) Representative flow cytometry plots showing separation of CD45+CD3NK1.1+NKp46+ T1-ILCs using CD49a and DX5 cell surface markers into double
negative (DN), innate lymphoid type 1 like (ILC1), double positive (DP) and conventional NK cells (cNK) in spleen, liver, and epididymal adipose with descriptive
diagram naming each subset in the quadrant (right).
(B) Representative cytometry histograms of Eomesodermin (Eomes) expression in T1-ILCs subsets.
(C) Representative cytometry plots of NKp46+CD3 T1-ILC subsets in adipose tissue from Tbx21+/+ and Tbx21/ mice.
(D) Representative cytometry plot of T1-ILCs in adipose from Nfil3/ and Nfil3+/+ mice.
(E) Histograms of cell surface expression of tissue residency-associated (CD69), activation, and maturation (CD62L, Thy1, and KLRG1) markers.
Error bars represent SEM. Data representative of two to three independent experiments, n = 2–5 mice per group. Statistical comparisons by unpaired two-tailed
Student’s t test. *p < 0.05, **p% 0.01, ***p < 0.001. See also Figure S2.were found at residual level (<5%). In contrast, splenic cNK
cells represented the majority (>90%) of NK cells, while in
liver, cNK cells and ILC1 populations represented 70% and
25%, respectively, as previously reported (Figure 2A; Sojka
et al., 2014).
Deciphering the biology of T1-ILCs is a fast-evolving topic
and subset-specific markers are frequently updated. In mice,
the current standard is to examine their capacity to produce276 Immunity 46, 273–286, February 21, 2017IFN-g and their developmental requirement of T-bet. More
recently, the use of Eomes (Eomesodermin) reporter mice
showed differential expression of Eomes and T-bet by cNK cells
and ILC1s (Daussy et al., 2014). Eomes+ ILC1s (cNK cells) is
distinguished from Eomes ILC1s derived from distinct precur-
sors (Cortez and Colonna, 2016; Seillet and Belz, 2016; Serafini
et al., 2015). However, the identification of salivary gland Eomes+
ILC1s is an exception to this rule (Cortez et al., 2014, 2016). Here,
we analyzed intracellular expression of Eomes in each subset in
spleen, liver, and adipose (Figure 2A, middle). As expected, the
majority of T1-ILCs in spleen were Eomes+, and the ILC1 subset
in liver was Eomes as previously reported (Daussy et al., 2014;
Gordon et al., 2012; Sojka et al., 2014). In adipose, cNK cells and
DP AT1-ILCs expressed Eomes at levels similar to splenic and
hepatic cNK cells. However, a significant fraction of DN and
ILC1-like subsets did not express Eomes (15% and 60%,
respectively, Figure 2B), suggesting heterogeneous transcrip-
tional programming. Next, we determined the developmental de-
pendency on Tbet for each AT1-ILC subset using Tbet-deficient
(Tbx21/) mice and found that the frequency and the density of
cNK and DP cell subsets were dramatically decreased while DN
cells were significantly increased in AT, compared to Tbx21+/+
mice. However, the level of ILC1-like subset was not affected
by the absence of Tbx21 (Figures 2C and S2B). This differential
requirement for Tbx21 for AT1-ILC subsets was similar in BAT
(Figure S2C). Remarkably, we found that ILC1-like subset was
predominantly Eomes+ in Tbx21/ mice and that all Eomes
cells were depleted in adipose and elsewhere (Figure S2D).
Similar to Sun et al. (2011), we found that Eomes AT1-ILCs
are strictly dependent on Tbx21 unlike the Eomes+DX5 identi-
fied as immature NK (iNK) cells that double in frequency in the
absence of Tbx21 (Figure S2E, top; O’Sullivan et al., 2016). How-
ever, we also found that in Tbx21/mice, the percent of CD49a+
cells is increased 2-fold within the iNK cell subset (Figures 2C
and S2E). In WT mice, CD49a+ is a mixed population composed
of Eomes+ iNK cells and Eomes ILC1s. The expansion of
Eomes+ iNK cells in Tbx21/ mice suggest that iNK cells could
acquire some attributes of ILC1s such as the expression of
CD49a to maintain the presence of this subset at the physiolog-
ical level.
Next, we examined the dependency on the transcription factor
Nfil3, which encodes Nuclear Factor Interleukin-3 (E4BP4). The
developmental requirement on Nfil3 is different among T1-ILCs
subsets in each tissue, with cNK cells requiringNfil3 for develop-
ment while other ILC populations do not (Diefenbach et al., 2014;
Serafini et al., 2015). Here, using Nfil3/ and littermate control
Nfil3+/+ mice, we found that the percentage of total AT1-ILCs
was dramatically reduced (15-fold decrease, Figures 2D and
S2F) as were cNK cells in blood in Nfil3/ mice. Thus, AT1-
ILC subsets are uniformly dependent on Nfil3.
We next investigated the maturation level of each AT1-ILCs
subset, based on the expression of CD27 and CD11b. NK
cell maturation is a 4-stage process that begins at CD11blo
CD27lo (stage 1), followed by the proliferative stage which are
CD11bloCD27hi (stage 2). In stage 2, NK cells start to acquire
their NK cell receptor repertoire and in stage 3 (CD11bhiCD27hi)
and stage 4 (CD11bhiCD27lo), they acquire their full effector po-
tential (diagram in Figure S2G, bottom; Chiossone et al., 2009).
Interestingly, we found that each of the AT1-ILC subsets had a
distinct maturation level (Figure S2G). The least mature subsets
were the adipose ILC1-like subset and the DN subset (stage
2/3), while the DP subset was at intermediate maturation
stage 3. Finally, cNK cells were mainly terminally differentiated
cells (65% CD11b+), compared to the cNK cells in spleen and
liver, which expressed lower levels of CD11b+ cells (35% and
50%, respectively). KLRG1 expression can also mark terminal
maturation in NK cells (Vosshenrich et al., 2005), and adiposeDP and cNK cells also expressed more KLRG1 compared to
DN and ILC1-like cells. KLRG1 expression inversely correlated
with Thy1 expression, a marker associated with early develop-
ment of NK cells. Thus, the maturation profile of AT1-ILCs is
heterogeneous, distinct from liver and spleen, and comprises
a large proportion of ‘‘immature-like’’ cells. Activated NK cells
upregulate early activation marker CD69 and downregulate
L-Selectin (CD62L) (Diefenbach et al., 2014), which are also
features of tissue residency. Adipose ILC1-like and DN NK
cells expressed higher levels of CD69 than DP and cNK cells.
However, unlike hepatic ILC1s, all AT1-ILC subsets expressed
CD62L (Figure 2E). Combined, we define AT1-ILCs as Nfil3
dependent and composed of subsets with differential require-
ment and expression of Tbet and Eomes. Thus, to align with
up-to-date nomenclature (O’Sullivan et al., 2016), we designate
three major AT1-ILC subsets as DN subset as immature
NK (iNK); CD49a+ ILC1-like subset (mixed ILC1s); and cNK sub-
set as mature NK (mNK), in addition to a minor DP subset
(Figure S2H).
Distinct Effector and Trafficking Properties for Mouse
Adipose NK Cell Subsets
T1-ILCs are characterized by their cytotoxic potential and their
capacity to produce IFN-g (Cortez and Colonna, 2016; Seillet
and Belz, 2016; Serafini et al., 2015). We next explored effector
functions and found that adipose iNK cell and mixed ILC1 sub-
sets expressed very little granzyme B unlike mNK cells. Interest-
ingly, unlike hepatic ILC1s, adipose mixed ILC1 subsets are
devoid of TNF-a receptor TRAIL and express granzyme B at
low levels (Figure 3A). To investigate IFN-g production in vivo,
we used IFN-g-reporter mice (Ifngtm3.1Lky) (Reinhardt et al.,
2009). All AT1-ILC subsets expressed IFN-g but mixed ILC1
population expressed the highest level of IFN-g, compared to
mNK cells (Figure 3B). As previously shown (Figures 1G and
1H), AT1-ILCs are predominantly resident. The heterogeneous
nature of adipose NK cells led us to further examine the traf-
ficking characteristics of each subset in adipose tissue. Using
parabiosis, we found that mNK cells recirculate through adipose,
evidenced by almost total chimerism (50% in each parabiont).
In stark contrast, there was very little recirculation in the DP,
mixed ILC1, and iNK cell populations, indicating that they are
predominantly resident. This was also in contrast to the equiva-
lent populations (albeit found at negligible levels) in the spleen
(Figure 3C). Collectively, our findings indicate that the adipose
NK cell pool is comprised of unique AT1-ILCs, including tissue-
resident iNK, mixed ILC1 and DP cells, and a minor circulating
mNK subset, and that each subset has distinct transcrip-
tional programming, maturation levels, activation, and effector
functions.
Human Adipose Tissue Contains Distinct ILC Group 1
Subsets
The study of human ILCs remains technically challenging due to
some ambiguity in the phenotypic and functional definition of
each subset and to the heterogeneity of T1-ILCs among different
tissues and organs (Bjo¨rkstro¨m et al., 2016; Spits et al., 2016).
Little is known about T1-ILCs, including NK cells, in human adi-
pose.We analyzedmatched blood and visceral omental adipose
tissue from previously obese patients undergoing abdominalImmunity 46, 273–286, February 21, 2017 277
Figure 3. Distinct Effector Signatures between Adipose DX5–CD49a+ ILC1-like and DX5–CD49a– DN Cells yet Both Are Tissue Resident
(A) Representative cytometry histograms (top) and quantitation (bottom), percentages of Granzyme B+ (GrzmB) and the death receptor TRAIL+ cells in each T1-
ILCs subset in matched spleen, liver, and adipose.
(B) Representative cytometry histograms (top) and quantitation (bottom) of Ifngtm3(EYFP)Lky; results are normalized to those of conventional NK cells subset in
matched spleen, liver, and adipose.
(C) Parabiotic mice: Contour plots gated on NK cell subsets (DN, ILC1-like, DP, and cNK) from spleen and adipose of the CD45.1member of a parabiotic pair after
15 days of parabiosis show the relative frequencies of CD45.1 (host) and CD45.2 (parabiotic partner) T1-ILC subsets in each tissue. Graph of chimerism of T1-
ILCs subsets in each organ.
Data representative of 2–3 independent experiments, n = 2–5 mice per group, and parabiosis: 5 pairs. Error bars represent SEM. Statistical comparisons using
unpaired two-tailed Student’s t test. *p < 0.05, **p% 0.01, ***p < 0.001.plastic surgery. Human peripheral blood typically contains
CD56brightCD16+ (95%) and CD56dimCD16 (5%) NK cells,
which are functionally distinct. We consistently found that
human adipose is devoid of CD56bright subset. Almost half
of the CD56dim subset did not express CD16, unlike in blood
(Figure 4A). Adipose CD56dimCD16+ cells were predominantly
CD127CD161+, characteristic of peripheral NK (pNK) cells,
but expressed Eomes at lower levels. The CD56dimCD16 sub-
set expressed very low levels of CD127 and higher levels of
CD161 and did not express Eomes, which is a similar phenotype
to a tonsil and gut CD127+ ILC1 population recently described
(Bernink et al., 2013, 2015), with an important distinction of
CD56 expression in adipose that was not reported in tonsil and
gut ILC1s (Figure 4B). In addition, CD69 was expressed at higher
levels, suggesting a more activated state and residency signa-
ture compared to blood (Figure 4C). We also found differential
cytotoxic potential between the two AT1-ILCs subsets, where
CD56dimCD16 NK cells expressed significantly less granzyme
B and Perforin, another common feature of CD127+ ILC1s,
compared to higher levels of perforin and granzyme B in the
CD56dimCD16+ pNK-like subset (Figure 4E). Hence, like murine
adipose tissue, we describe novel human AT1-ILCs subsets
including a CD56+CD127lo ILC1-like population that is enriched
in human adipose that appears to have less cytotoxic potential
in resting conditions.278 Immunity 46, 273–286, February 21, 2017AT1-ILCsDynamically Respond and Adapt to Changes in
Diet in Humans and Mice
One of the unique features of AT is its plasticity to rapidly expand
and contract in response to changes in energy supply through
the diet (Rosen and Spiegelman, 2014). Recent studies have
shown that several immune subsets in adipose tissue also
respond to changes in diet (Exley et al., 2014). In mice, it was
recently reported that AT1-ILC absolute numbers increased in
obesity (4–12 weeks high-fat diet [HFD]) (Lee et al., 2016;
Wensveen et al., 2015); however, recent work reported that their
density remained unchanged (O’Sullivan et al., 2016). We first
asked how AT1-ILCs in humans respond to obesity and weight
loss. We have previously shown that NK cell levels are severely
reduced in the blood of patients with obesity, compared to
lean age-matched controls (Lynch et al., 2009b). Here, we found
that obese omental adipose tissue has a lower frequency of AT1-
ILCs compared to lean omental tissue in humans (12% versus
5%; Figure 5A). Next, we asked whether weight loss would
alter the T1-ILCs levels in the periphery by looking cross-section-
ally at patients before and after bariatric surgery. Confirming our
previous findings, we found reduced levels of T1-ILCs in obese
patients (BMI > 40) compared to lean controls in a cross-
sectional study. However, T1-ILCs levels significantly increased
18 months after bariatric surgery, when BMI was significantly
lower, although still in the obese range (Figure 5B). We also
Figure 4. Human Adipose Tissue Is Enriched with Unique CD56dimCD16– NK Cell Subset with Poor Cytotoxic Potential in Obesity
(A) Representative flow cytometry plots of human T1-ILCs subsets in matched blood and omental adipose tissue from obese and ex-obese individuals (n = 6).
Error bars represent SEM.
(B–D) Histograms of (B) development, (C) maturation/activation, and (D) cytotoxicity in matched blood and omental adipose of obese individuals.followed six patients longitudinally and found that there was a
significant increase in T1-ILCs in each patient after weight loss
through bariatric surgery (5% versus 10%; Figure 5B, left).
Thus, we found that AT1-ILC levels are reduced during chronic
obesity but could recover to near normal levels upon restricted
food intake in humans. Next, we conducted a more detailed
analysis on mice to follow the dynamics of AT1-ILCs at the onset
of obesity. Within the first 96 hr of starting a HFD, during which
time the mice are not yet obese but have significantly larger
epididymal fat pads, AT1-ILC frequency and number increased
by 72 hr and further increased by 96 hr of switching to a HFD
(Figure 5C). However, after prolonged HFD feeding (12 weeks
to 8 months) when obesity is established, the proportion of
AT1-ILCswithin the lymphoid compartment cells was decreased
(Figures 5D and S3A). We then examined the response of AT1-
ILCs to weight loss in mice. We removed the HFD from obese
mice with established obesity (8 weeks HFD) and replaced it
with a standard fat diet (SFD) for 4 weeks. As expected, the
mice lost significant body and fat pad weight and AT1-ILCs
were restored to the normal frequency (Figure 5D). Thus, AT1-
ILC levels rapidly responded to changes in diet, weight loss,
and weight gain in mice and humans.
As AT1-ILCs increased at the beginning of HFD feeding (Fig-
ure 5C), we next examined whether this increase was due to
local proliferation or to infiltration from the periphery. We gener-
ated parabiotic mice as before, but this time, we fed one group a
HFD for 7 days (starting 7 days after surgery) and the other group
only a SFD. We also injected BrdU into each parabiotic mouse in
the pair in both the SFD and HFD groups, every 48 hr for the
duration of the experiment (Figure 5E). In the HFD group, AT1-
ILCs significantly increased (Figure S3B), illustrating that HFD
feeding has a similar impact after parabiotic surgery as in non-
parabiotic WT mice. AT1-ILC chimerism was also increased,
illustrating that HFD feeding induced NK cell infiltration fromthe periphery (Figure 5F). To rule out the possibility that only in-
filtrated cells may have proliferated, which would lead to the
appearance of increased chimerism, we measured BrdU incor-
poration in the CD45.1 and CD45.2 AT1-ILCs during the course
of parabiosis. We found similar percentages of proliferating AT1-
ILCs in SFD- or HFD-fed mice (Figure S3C). However, the num-
ber of AT1-ILCs proliferating was increased, due to the increase
in total number of AT1-ILCs after HFD (Figure 5G). To determine
the source of the proliferating AT1-ILCs, total BrdU+ T1-ILCs
were gated, and their origin (CD45.1 or CD45.2 derived) was
analyzed. In both SFD- and HFD-fed mice, the majority of prolif-
erating AT1-ILCs were not partner derived, suggesting that they
were endogenous, although infiltrating T1-ILCs also proliferated
in situ in adipose tissue (Figure S3D). There was no difference
between the proportions of endogenous versus infiltrating T1-
ILCs that were proliferating between the SFD or HFD pairs (Fig-
ure S3D, right). As a control, we alsomeasured T1-ILC levels and
chimerism in blood. There was an increase in circulating T1-ILC
levels in parabiotic pairs under this short-term HFD (Figure S3E),
but no difference in chimerism (Figure S3F), suggesting that the
increased infiltrating AT1-ILCs in HFD come from an increased
pool in the periphery. Taken together, using parabiosis in diet-
induced obesity models for the first time, we show that T1-
ILCs infiltrate into adipose tissue at onset of obesity. While
infiltration was the primary source of the increase in AT1-ILCs,
there was also an increase in the number of proliferating
AT1-ILCs, which together with increased infiltration cumulatively
accounted for increase in AT1-ILCs in adipose tissue during HFD
feeding.
As the AT1-ILCs population comprises three phenotypically
and functionally distinct subsets, some of which are unique to
AT and have distinct trafficking patterns, we next asked whether
they had a differential response to obesity. We found a signifi-
cant increase in the proportion of the mNK cell subset afterImmunity 46, 273–286, February 21, 2017 279
Figure 5. T1-ILCs Have a Dynamic Response to Weight Gain and Loss in Mice and Humans
(A) Representative cytometry contour plots (left) and quantitation (right) of T1-ILC percentages in human adipose from lean and obese individuals.
(B) Body mass index (BMI, left), at pre- and post-bariatric surgery. Middle: percent of peripheral blood T1-ILCs in cross-sectional (n = 12–15 unmatched patients)
and longitudinal (right, n = 6 matched patients, paired t test) studies.
(C) Representative cytometry plots of epididymal AT1-ILCs from HFD time course of 0 hr (SFD) to 12, 24, 36, 48, 72, and 96 hr of HFD, and AT1-ILC levels (middle)
and numbers (right) from each mouse during HFD.
(D) Percentages of AT1-ILCs of lean (SFD), short-term (5 days) and long-term (8 weeks) HFD, and after 4 weeks of returning to SFD after 8 weeks of feeding with
HFD (n = 5–8 per group, unpaired t test).
(E) Diagram of experimental set up to study T1-ILC circulation and proliferation at the onset of obesity. Schematic: Parabiotic pairs were fed a SFD for 3 days, then
HFD for 2 weeks (top), compared to SFD (bottom). BrdU was i.p. injected on day 1 after surgery and every second day for 2 weeks.
(F and G) Quantitation of level of chimerism (F) and number of proliferating ILC1s (G) (see Figures S3B–S3F).
(H) Cytometry contour plot (left) and proportions (right) of T1-ILC subsets in spleen and adipose from SFD- and HFD (4 weeks)-fed mice (n = 2–3 mice per group,
2 independent experiments).
Error bars represent SEM. Statistical comparisons using unpaired two-tailed Student’s t test. *p < 0.05, **p% 0.01, ***p < 0.001. See also Figure S3.
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Figure 6. ATMs Express Stress Ligands at Steady State and in Obesity and Interact with AT1-ILCs
(A) ATM levels as a percentage of CD45+ cells (left) and numbers (right) after early and prolonged HFD intake (120 days). Macrophages were gated as
CD45+F480+CD11b+ and levels measured as a percent of CD45+ cells.
(B) Rae1 immunostaining of white adipose tissue.
(C) Cytometry histograms of Rae1 expression in F4/80+ adipose macrophages in SFD and HFD (8 weeks) mice.
(D) Immunofluorescence staining of adipose tissue from Ncr1+/gfp mice showing close contact (arrowhead) of NKp46+ NK cells (green) and CD68+ macro-
phages (red).HFD, in agreement with our conclusion that the increase in total
AT1-ILCs in obesity accounts mostly from infiltration of mNK
cells from the periphery (Figure 5H). As a result, there was
a decrease in the proportion of the tissue-resident AT1-ILC
subsets (DP, iNK, and mixed ILC1s) after HFD. Similar observa-
tions were made in BAT and subcutaneous (Sub-C) adipose
(Figure S3G).
Taken together, our data show that AT1-ILC levels and dy-
namics are rapidly altered by changes of diet; mNK cells infiltrate
adipose tissue at the onset of obesity, and the overall AT1-ILCs
are later decreased after chronic obesity but can be restored to
normal levels with weight loss.
ATMsExpress Stress Ligands at Steady State and during
Obesity
Obesity-induced inflammation is associated with aberrant ATM
expansion (Amano et al., 2014). By tracking ATM kinetics in
HFD-fed mice, we found that ATMs, like AT1-ILCs, quickly
respond to HFD. Unlike AT1-ILCs, ATMs keep expanding after
prolonged HFD (Figure 6A). Obesity-induced inflammation is
partly due to the adipose stress response to excess energy
intake and storage. We looked for stress signals that T1-ILCs
including NK cells would recognize. By immunohistochemistry,
we detected Rae-1+ cells in obese adipose tissue (Figure 6B).
Rae-1 is an NKG2D ligand upregulated in stressed cells, making
them potential targets of NK cell cytotoxicity (Raulet et al., 2013).
By flow cytometry, we found that ATMs were the main cell
expressing Rae-1 at steady state in lean adipose tissue (Fig-
ure 6C), which was unusual as these stress ligands are not typi-
cally expressed at steady state. Furthermore, Rae1 levels were
increased on ATMs during HFD. NK cells can interact with mac-rophages through NKG2D-Rae1 during infection or LPS-induced
inflammation (Raulet et al., 2013). By confocal microscopy and
using NKp46-GFP reporter mice (Ncr1gfp), we observed that
AT1-ILCs and adipose macrophages (CD68+) were both distrib-
uted around adipocytes and in most cases were proximal to
each other (Figure 6D), suggesting that they may interact at
steady state.
AT1-ILCs Are Necessary and Sufficient for Regulating
ATM Homeostasis through Targeted Cytotoxicity
Given the expression of stress ligands on ATMs, we asked
whether AT1-ILCs might kill ATMs. We sorted and co-cultured
autologous AT1-ILCs and ATMs from lean mice. Interestingly,
AT1-ILCs killed macrophages from lean mice ex vivo, in a
dose-dependent manner, as measured by the number of dead
macrophages and the degranulation of AT1-ILCs (Figures 7A
and S4A). AT1-ILCs killed M2 macrophages more effectively
than M1 (Figure 7B). We reasoned that if a physiological role of
AT1-ILCs involved regulation of macrophages through directed
cytotoxicity, then depleting AT1-ILCs should affect ATM homeo-
stasis. To test this, we depleted AT1-ILCs by anti-asialo GM1
(aGM1) injections for 1 week. aGM1 was used as anti-NK1.1
can also deplete iNKT cells, and anti-aGM1 uniformly ablated
all AT1-ILCs (Figure S4B). Depletion of AT1-ILCs resulted in a
significant increase in ATM number and proportion (Figure 7C).
Importantly, a significant increase in M2 macrophages ac-
counted for most of the increased ATMs (Figure 7D). The surface
expression of stress ligands Rae1 in ATMs at steady state
prompted the question of whether ATM killing was NKG2D
dependent. We found a trend in decreased M1 levels (p = 0.06)
and an increase in M2:M1 ratio (p = 0.07) in NKG2D-deficientImmunity 46, 273–286, February 21, 2017 281
Figure 7. AT1-ILCs Are Necessary and Sufficient for Homeostasis ATMs
(A and B) Representative contour cytometry plots of total ATMs stained with PI (A) and percent of dead ATMs after co-incubation with autologous AT1-ILCs at the
indicated ratios (B) (n = 10 mice, 2–3 biological replicates, 3 experiments).
(C) Cytometry dot plots and quantifications of total ATMs in AT1-ILCs depleted with anti-asialo GM1 (aGM1) and PBS control mice.
(D) Contour plots and quantification of M1 and M2 of ATMs in SFD mice after AT1-ILC depletion with aGM1 (n = 3–7 mice per group, two experiments).
(E) Representative dot plot and calculation of M2:M1 ratio in SFD-fed Pfr1/ and Prf1+/+ mice.
(F) Representative cytotoxic assay with adipose AT1-ILCs co-incubated with ATMs target cells from either SFD-fed (S) or HFD-fed (H) mice at the indicated AT1-
ILC:ATM ratios (n = 10 mice per group, two independent experiments).
(G) Representative cytometry plots and quantification of total ATMs and gated M1 (red) andM2 (blue) in obese mice adoptively transferred with total lean-derived
AT1-ILCs (n = 2–3 injected mice per group with n = 10 donor mice, two independent experiments).
(H) Fasting blood glucose (right), glucose test tolerance (middle), and area under the curve (AUC, right) of adoptively obeseWTmice after adoptive transfer of total
AT1-ILC subsets derived from WT lean donor mice or PBS.
Error bars represent SEM. Statistical comparisons using unpaired two-tailed Student t test. *p < 0.05, **p% 0.01, ***p < 0.001. See also Figure S4.(Klrk1/) compared to NKG2D-sufficient (Klrk1+/+) lean mice
(Figure S4C). Similar results were obtained in obesity settings
(Chung et al., 2014). Thus we conclude that expression of
NKG2D stress ligands on ATMs may play an important role,282 Immunity 46, 273–286, February 21, 2017but NKG2D-ligand interaction may be redundant in regulating
ATM homeostasis and other pathways may be involved. To vali-
date the importance of cytotoxicity in regulating ATM levels at
steady state, we examined ATM in perforin-deficient mice
(Prf1/). The AT1-ILC compartment was normal in Prf1/mice
(Figure S4D). Similar to AT1-ILC-depleted mice, the levels of M2
macrophages were increased in Prf1/mice leading to a signif-
icantly greater M2:M1 ratio, compared to Prf+/+mice (Figure 7E).
Thus, AT1-ILCs have the ability to kill macrophages in adipose
tissue at steady state, particularly M2 macrophages, and this is
important for ATM homeostasis.
Obesity Interferes with AT1-ILC Cytotoxicity
We have shown that AT1-ILCs are reduced in established
obesity in humans (Figure 5A) and mice (Figure 5D). We hypoth-
esized that reduced levels of AT1-ILCs and/or their functional
defect in cytotoxicity in obesity may play a role in ATM expansion
in obesity. To explore this, we performed cytotoxicity assays
with isolated AT1-ILCs and ATMs from SFD (S)- or HFD (H)-fed
mice (Figure 7F). As shown before, AT1-ILCs from SFD-fed
mice killed ATMs from SFD-fed mice, but killed ATMs from
HFD more effectively. However, AT1-ILCs from obese mice
had significantly reduced ability to kill ATMs from HFD-fed
mice, suggesting that prolonged obesity may impair their killing
capacity. As well as infiltration, ATMs have been shown to prolif-
erate in situ, which is enhanced in obesity (Amano et al., 2014).
Once again, we found that depleting AT1-ILCs caused a dra-
matic increase in proliferating ATMs in lean mice. However, in
obese mice, depleting AT1-ILCs did not affect ATM proliferation,
also suggesting that AT1-ILCs lose their ability to regulate
ATMs in obesity (Figure S4E). Finally, we investigated whether
AT1-ILCs from lean mice were sufficient to reduce ATMs in
HFD-fed obese mice. Adoptive transfer of AT1-ILCs from lean
mice into obese mice resulted in a significant reduction in ATM
levels and numbers (Figure 7G, top). The effects of adoptive
transfer of AT1-ILCs reduced both M1 and M2 numbers, but
the effects on M2 macrophages were more pronounced and
resulted in a significant increase in the M1:M2 ratio (Figure 7G,
bottom). Thus, our findings show that AT1-ILCs are necessary
and sufficient for maintaining ATMs homeostasis at steady state
but during obesity, this cytotoxic regulatory function is lost,
which may account for the uncontrolled expansion of ATMs.
As AT1-ILCs comprise at least three subsets, we next investi-
gated whether one or more subset could kill ATMs. We cell
sorted CD49a+ mixed ILC1, iNK cell, and mNK cell subsets
from WT lean donor mice and adoptively transferred equal
numbers of each subset into recipient obese mice. All AT1-ILC
subsets could reduce ATM frequencies and numbers in vivo in
obese mice, albeit to slightly different degrees (Figure S4F,
left). Both M1 and M2 macrophages were reduced in number,
agreeing with our findings that AT1-ILCs can kill both M1 and
M2macrophages (Figure S4F, right). Transfer of all AT1-ILC sub-
sets resulted in reducedM2 numbers in adipose tissue, although
with slightly differing levels; iNK cell transfer results in the bigger
reduction in both M1 and M2 macrophages, while transfer of
mNK cells impacted ATMs to a lesser extent. We also tested
the killing ability of each AT1-ILC subset in vitro against autolo-
gous ATMs from lean mice. Again, all AT1-ILC subsets could
kill autologous ATM in vitro, and iNK cells were the most efficient
killers (Figure S4G). These subsets also had the highest level of
degranulation (Figure S4H). Given that transfer of all AT-ILCs in-
creases the M1:M2 ratio in adipose tissue, their depletion in-
creases M2 macrophages in adipose tissue and each subsetproduces IFN-g, so we hypothesized that this would negatively
impact systemic metabolism. Fasting blood glucose levels
and impaired glucose handling were significantly higher in
mice that received total AT1-ILCs compared to vehicle alone
(Figure 7H). Our results agree with the link between AT1-ILCs
and metabolic homeostasis recently reported. We also highlight
subtle differences in the contribution of each subset to macro-
phage homeostasis, although the net effect of AT1-ILCs is tar-
geted cytotoxicity against macrophages, particularly of the M2
phenotype, and production of IFN-g. Together, we demonstrate
unique functions of AT1-ILCs in regulating ATM homeostasis at
steady state and we propose that obesity-associated loss of
cytotoxic function accounts for ATM accumulation and glucose
intolerance.
DISCUSSION
Innate lymphoid cells (ILCs), including NK cells, are important
regulators of tissue homeostasis, inflammation, and repair (Die-
fenbach et al., 2014). Here we identified unique AT1-ILC subsets
in human and mouse adipose tissue. In mice, AT1-ILCs included
circulating mNK cells while the majority were tissue-resident iNK
and CD49a+ mixed ILC1 subsets. We found that AT1-ILCs and
macrophages interact in adipose tissue, which resulted in ATM
death and homeostatic regulation at steady state. Indeed, adop-
tive transfers or depletion of T1-ILCs show that NK cells are
necessary and sufficient to regulate macrophage homeostasis.
Our data show a new mechanism by which macrophages are
kept in check by AT1-ILC cytotoxicity to prevent aberrant expan-
sion. In chronic obesity, AT1-ILCs were decreased in numbers
and their killing ability against ATMs in vitro was significantly
impaired. This loss of function may be at least partly responsible
for the increase in macrophages associated with obesity, as
transfer of ‘‘lean’’ AT-ILC1 subsets were sufficient to reduce
adipose macrophages number and frequency in obesity. Taken
together, our data suggest that regulating ATM homeostasis is a
key role of AT1-ILCs.
Interestingly, within the three AT1-ILC subsets, the expression
of Eomes did not correlate with DX5 or CD49a expression, and
the CD49a+ subset (identified as mixed ILC1s) was composed
of Eomes ILC1s and Eomes+ iNK cells. Using Eomes reporter
mice, similar AT1-ILC subsets were recently characterized
(O’Sullivan et al., 2016). However, by analyzing the requirement
of Tbet for AT1-ILC subsets using a different gating strategy,
we found that the presence of CD49a+ was maintained indepen-
dently of Tbx21 and that this population was composed of
Eomes+ iNK cells. This suggests that iNK cells could acquire
ILC1 attributes to preserve this CD49a+ compartment when
compensation is required. In addition, the residency of some
AT1-ILCs was not exclusively tied to CD49a expression. Instead,
iNK cells were CD49a but were mainly tissue resident in our
parabiosis experiments. Adipose CD49a+ mixed ILC1s ex-
pressed the most IFN-g, the least granzyme B, and no TRAIL,
unlike ILC1s in liver. In humans, visceral omental adipose
tissue showed a similar enrichment of an unconventional
CD16CD56loCD127lo ILC1-like population with low expression
of cytotoxic molecules. In human adipose, peripheral-like
CD16+CD56lo were found at low levels and CD16CD56bright
CD127+cellswere virtually absent. Thequestionofwhether theseImmunity 46, 273–286, February 21, 2017 283
adipose ILC1-like subsets are developmental intermediates un-
dergoing ILC1 or NK cell conversion needs further investigation,
but we have described distinct populations with specific effector
molecules, found in all patients regardless of age or BMI, sug-
gesting that AT1-ILC subsets have specific functions distinct
from peripheral conventional NK cells.
We found that AT1-ILCs rapidly respond to changes in diet, in
both human and mice. iNKT are also tissue resident in adipose
and they dramatically decreased in human and murine obesity
(Lynch et al., 2009a, 2012). Here, we showed by parabiosis
that peripheral T1-ILC levels rapidly increased in blood and infil-
trate adipose tissue within the first days of starting HFD in mice.
This dynamic response is similar to that of monocyte and
macrophage infiltration to adipose tissue in early-stage obesity.
However, there were some differences between the macro-
phage and T1-ILC response; while macrophages continue to
accumulate in adipose tissue throughout obesity, the overall
percentage of total AT1-ILCs is decreased in both humans
and mice during prolonged obesity. We also found that blood
and adipose T1-ILCs were able to reverse to normal levels
upon weight loss in both humans and mice, revealing that
AT1-ILCs are dynamic diet or energy sensors. Recent studies
reported a negative impact of AT1-ILCs on metabolic health
and accounted this effect to AT1-ILC-induced promotion of
M1 expansion (Lee et al., 2016; Wensveen et al., 2015). Two
studies found that this was through increased production of
IFN-g by AT1-ILCs in obesity (O’Sullivan et al., 2016; Wensveen
et al., 2015), while the other study found no increase in IFN-g
but rather an increase in TNF-a production by AT1-ILCs in
HFD (Lee et al., 2016). We also observed a decrease in percent-
age of pro-inflammatory M1 macrophages in AT1-ILC-depleted
mice in agreement with the previous studies (O’Sullivan et al.,
2016; Wensveen et al., 2015). However, given the effect of
AT1-ILCs on macrophage killing, it is possible that the effects
of AT1-ILCs on M1 macrophages are secondary or complimen-
tary to the direct effects of AT1-ILC killing of macrophages, pri-
marily M2 macrophages. T1-ILCs can kill M2 macrophages
in other circumstances, while M1 macrophages are resistant
to T1-ILC cytotoxicity (Bellora et al., 2010). Nevertheless, our
data revealed an unexpected finding, as the dogma states
that M2 macrophages have many beneficial effects on tissue
homeostasis and dampening inflammation (Fischer-Posovszky
et al., 2011). Thus, it is puzzling as to why they would be targets
of AT1-ILC cytotoxicity, naturally, without infection or HFD or
changes in surface expression of MHC class I (not shown).
One possibility is that M2 macrophages are very active in lean
adipose tissue, remodeling and surveying for dying adipocytes
or other potential hazardous extracellular material to engulf.
Once they have fulfilled their role in buffering from potentially
dangerous material, they may upregulate ‘‘kill me’’ signals to
prevent inflammation. Thus the T1-ILC-M2 macrophage rela-
tionship may play an important homeostatic role in preventing
the development of stressed pro-inflammatory macrophages
in adipose tissue. However, obesity may override this system,
with the loss of AT1-ILCs within the adipose lymphoid compart-
ment, the loss of their killing potential, and the dysregulation
of macrophages. On the other hand, upregulation of AT1-
ILCs-obese-derived IFN-g may further contribute to insulin
resistance. Here, by studying the metabolic outcome of lean-284 Immunity 46, 273–286, February 21, 2017derived AT1-ILCs that are still competent for both killing poten-
tial and IFN-g production at physiological level, we found that
the AT1-ILC cytotoxicity resulted in reduced M2 macrophages
and more severe glucose intolerance. Thus, we propose a novel
‘‘physiological killing’’ of macrophages by adipose AT1-ILCs
to maintain adipose homeostasis at steady state, hereby high-
lighting the importance of understanding ILC and macrophage
interactions in health and disease.
EXPERIMENTAL PROCEDURES
Mice
Male (and where indicated, female) wild-type (WT) C57BL/6, Tbx21/ (Finotto
et al., 2002), Pfrn/ (C57BL/6-Prf1tm1Sdz/J [K€agi et al., 1994]), and Ifngyfp/yfp
(GREAT/Ifngtm3(EYFP)Lky [Reinhardt et al., 2009]) mice were purchased from
Jackson Laboratories. Nfil3/ mice (Kamizono et al., 2009) were a kind gift
from Dr. Vijay Kuchroo. Where indicated, mice received either SFD or HFD
(Research Diets, 60 kcal% fat) from 6 weeks of age. Mice were housed under
specific-pathogen-free conditions. Animal experiments were performed in
accordance with protocols approved by the Institutional Animal Care and
Use Committee.
Subjects
10 mL of peripheral blood and visceral fat was obtained from obese subjects
undergoing bariatric surgery (mean BMI 48) and from ex-obese undergoing
plastic surgery after weight loss. Visceral, subcutaneous, mesenteric, and
peri-colic fat was also obtained from eight lean patients undergoing abdominal
surgery (two hernia repair, one rectal prolapse, and five resections). For cross-
sectional and longitudinal studies, we collected blood from a group of 12
obese patients before and 12 patients 18 months after bariatric surgery, and
we followed 6 individuals before and 12 patients 18 months after bariatric
surgery and collected their blood and BMI at these time points. All blood sam-
ples were obtained with written informed consent. The ethics committee at
Brigham andWomen’s Hospital, Boston, and St. Vincent’s University Hospital,
Dublin, granted approval for this study.
Cell Preparation
Adipose tissue was processed as previously described (Lynch et al., 2015) to
obtain a cell suspension of stromovascular cells (SVF). A detailed description
and staining reagents and procedures are detailed in the Supplemental Exper-
imental Procedures.
Parabiotic Surgery
Parabiosis was performed as previously described (Lynch et al., 2015) using
CD45.1+ andCD45.2+mice. Parabioticmicewere kept together for 2–3weeks.
One group received HFD for 2 weeks. Chimerism in the blood and tissues was
defined as the percent CD45.1+ cells over the percent of CD45.1+ cells and
vice versa.
Killing Assays
Sortedmacrophages were plated and labeled with Cell Trace Violet and sorted
adipose NK cells were added at the indicated effector:target (E:T) ratios. After
4 hr of co-incubation, propidium iodide was added to discriminate dead target
cells (macrophages), analyzed by flow cytometry.
Type 1 ILC Depletion
Anti-mouse Asialo GM1 (Ganglioside, ganglio-N-tetraosylceramide, clone
Poly21460, Biolegend) or PBS vehicle was i.p. injected to WT mice at 40 mL
per mouse every 2 days for a duration of 8 days.
Adoptive Transfer
50,000 sorted WT lean-derived AT1-ILCs (live CD45+NK1.1+CD3 singleton
lymphocytes) or 20,000 individual WT lean-derived AT1-ILC subsets—mNK
(DX5+CD49a), iNK (DX5CD49a), or mixed-ILC1 (DX5CD49a+)—were i.p.
injected in 100 mL of PBS to HFD-fed mice. PBS vehicle was similarly injected
as negative control.
Glucose Tolerance Test
After 6 hr of fasting, mice were injected with 1 g glucose per kg body intraper-
itoneally (i.p.), and glucose levels were measured before and every 20 min for
120 min after injection using an automated glucometer (LifeScan).
Statistics
Error bars represent SEM. The statistical significance of differences between
two groups was determined using theMann-Whitney U test or Student’s t tests
where appropriate after determination of Gaussian distribution of the data, or
by one-way ANOVA for groups of more than two, with Tukey post hoc test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2017.01.008.
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